Stephens Upgrades Abaxis Inc. (ABAX) to Overweight
Stephens upgrades Abaxis Inc. (Nasdaq: ABAX) from Equalweight to Overweight with a $24 price target. Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements in the medical and veterinarian...
Get Alerted When News Hits On This Stock - FREE!